The SLC17A5 gene Sialuria Finnish Type genetic test is a specialized diagnostic tool designed to identify mutations in the SLC17A5 gene, which are responsible for causing Sialuria Finnish Type, a rare genetic disorder. This condition is characterized by an excess of free sialic acid in the body, leading to various symptoms such as developmental delay, coarse facial features, and organomegaly. The test involves analyzing the patient's DNA to detect mutations in the SLC17A5 gene, providing crucial information for diagnosis, management, and genetic counseling of affected individuals and their families.
Performed at DNA Labs UAE, a leading facility in genetic testing, the cost of the SLC17A5 gene Sialuria Finnish Type genetic test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring accurate and reliable test results. This test is an important resource for families with a history of Sialuria Finnish Type, offering them the opportunity for early diagnosis and intervention.
The GPC3 gene test for Simpson-Golabi-Behmel Syndrome Type 1 is a specialized genetic screening offered by DNA Labs UAE. This test is designed to identify mutations in the GPC3 gene, which are linked to the development of Simpson-Golabi-Behmel Syndrome Type 1 (SGBS1), a rare genetic disorder characterized by pre- and postnatal overgrowth, distinctive facial features, and a variety of organ abnormalities. The condition is primarily seen in males and can have variable expressivity. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific genetic mutations associated with SGBS1.
The cost of the GPC3 gene test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results. Conducting the test at DNA Labs UAE ensures that patients receive accurate and reliable results, as the lab is equipped with state-of-the-art genetic testing technology and staffed by professionals with expertise in genetic disorders. This test is crucial for families seeking a diagnosis for symptoms consistent with Simpson-Golabi-Behmel Syndrome Type 1, as it provides essential information for managing the condition and understanding the risk of recurrence in future pregnancies.
The ALDH3A2 gene Sjogren-Larsson Syndrome genetic test is a diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the ALDH3A2 gene that are associated with Sjogren-Larsson Syndrome (SLS). Sjogren-Larsson Syndrome is a rare, inherited neurocutaneous disorder characterized by ichthyosis (scaly skin), intellectual disability, and spastic diplegia or quadriplegia. Mutations in the ALDH3A2 gene disrupt the metabolism of fatty alcohols, leading to the accumulation of toxic substances in the body, which in turn cause the symptoms of the syndrome.
This genetic test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the ALDH3A2 gene that are known to cause SLS. Identifying these mutations can confirm a diagnosis of Sjogren-Larsson Syndrome, allowing for early intervention, management of symptoms, and genetic counseling for affected families.
The cost of the ALDH3A2 gene Sjogren-Larsson Syndrome genetic test at DNA Labs UAE is 4400 AED. This price may cover the test itself, the expertise of the medical professionals conducting and analyzing the test, and any post-test counseling that may be necessary based on the results. It's important for potential patients to check if additional costs may apply and if their insurance may cover part of the cost. The test provides crucial information for affected individuals and their families and represents a significant step in managing the condition effectively.
The ARHGEF10 gene is implicated in the development and function of the peripheral nervous system, specifically in the myelination process of peripheral nerves. Mutations in this gene have been linked to slowed nerve conduction velocity, a condition that affects the speed at which electrical signals are transmitted through the nerves. This can lead to a range of neurological symptoms, including muscle weakness and sensory disturbances.
To diagnose conditions related to mutations in the ARHGEF10 gene, DNA Labs UAE offers a specialized genetic test. This test is designed to identify alterations in the ARHGEF10 gene that are associated with autosomal dominant inheritance patterns of slowed nerve conduction velocity. The autosomal dominant nature of the condition means that only one copy of the mutated gene, inherited from either parent, is sufficient to cause the disorder.
The test offered by DNA Labs UAE involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific mutations in the ARHGEF10 gene. This test is crucial for individuals who exhibit symptoms of slowed nerve conduction or have a family history of the condition, as it can provide a definitive diagnosis and guide treatment and management strategies.
The cost of the ARHGEF10 gene test at DNA Labs UAE is 4400 AED. This investment in genetic testing can be invaluable for affected individuals and their families, offering insights into the genetic basis of their condition and informing decisions about care and support.
The RAI1 Gene Smith-Magenis Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the RAI1 gene, which are associated with Smith-Magenis Syndrome (SMS). SMS is a developmental disorder characterized by distinctive facial features, developmental delay, behavioral problems, and sleep disturbances. The test plays a crucial role in the early detection and management of SMS, offering insights into potential interventions and support for affected individuals.
This genetic test involves analyzing the patient's DNA to look for specific alterations in the RAI1 gene that are known to cause Smith-Magenis Syndrome. Early diagnosis through this test can significantly benefit patients and families by providing them with a clear understanding of the condition, enabling access to targeted therapies, and support services, and facilitating informed decision-making regarding care and management.
At DNA Labs UAE, the RAI1 Gene Smith-Magenis Syndrome Genetic Test is priced at 4400 AED. This cost includes the collection of a DNA sample, usually through a blood draw or cheek swab, and its subsequent analysis in the laboratory. The price reflects the comprehensive nature of the test, encompassing the expertise required for accurate interpretation of the results and the provision of detailed genetic counseling to discuss the findings. This test represents a vital resource for families seeking answers about Smith-Magenis Syndrome, offering hope and direction in navigating the challenges associated with the disorder.
The ULK2 gene plays a crucial role in various cellular processes, including autophagy, which is the body's way of cleaning out damaged cells to regenerate newer, healthier cells. Mutations or abnormalities in the ULK2 gene have been linked to several genetic disorders, including Smith-Magenis Syndrome (SMS), a developmental disorder characterized by distinctive facial features, behavioral problems, sleep disturbances, and intellectual disability.
To assess the risk or presence of Smith-Magenis Syndrome and related conditions, DNA Labs UAE offers a comprehensive ULK2 Related Genetic Test. This test specifically targets the ULK2 gene to identify any genetic mutations that may be associated with SMS or related disorders. The procedure involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities.
The cost of the ULK2 Related Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the collection of the sample, the genetic analysis, and the provision of a detailed report that outlines the findings. The report is an essential tool for healthcare providers, helping them to understand a patient's genetic makeup, make accurate diagnoses, and tailor treatment plans effectively. For families and individuals, the test provides crucial insights into genetic risks, contributing to informed healthcare decisions and proactive management of potential health issues related to Smith-Magenis Syndrome and other ULK2 gene-related conditions.
The "SACS Gene Spastic Ataxia Charlevoix-Saguenay Type Genetic Test" is a specialized diagnostic tool designed to identify mutations in the SACS gene, which is known to cause Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS). ARSACS is a neurodegenerative disorder characterized by a wide range of symptoms including ataxia, spasticity, and peripheral neuropathy, typically emerging in early childhood. This genetic test is crucial for confirming the diagnosis, enabling early intervention, and facilitating family planning decisions for those with a history of the disorder. Conducted by DNA Labs UAE, a leading facility in genetic diagnostics, the test is priced at 4400 AED. The process involves collecting a DNA sample, usually through a blood draw, and analyzing it for specific mutations in the SACS gene, providing valuable information for affected individuals and their families.
The VAMP1 Gene Spastic Ataxia Type 1 Autosomal Dominant Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the VAMP1 gene, which are associated with Spastic Ataxia Type 1, an autosomal dominant neurodegenerative disorder. This condition is characterized by a combination of spasticity and ataxia, leading to difficulties in movement and coordination. The test is crucial for individuals with a family history of the disorder or those exhibiting symptoms, as it can confirm the diagnosis and facilitate appropriate management and treatment plans. The cost of the test is 4400 AED, making it an accessible option for those seeking genetic testing services in the United Arab Emirates. By identifying the specific genetic mutation, healthcare providers can offer personalized care, potentially improving the quality of life for affected individuals and their families.
The KIF1C Gene Spastic Ataxia Type 2 Autosomal Recessive Genetic Test is a specialized diagnostic tool designed to identify mutations in the KIF1C gene, which are linked to the development of Spastic Ataxia Type 2, a rare autosomal recessive disorder. This condition is characterized by progressive muscle stiffness (spasticity) and coordination problems (ataxia), affecting an individual's ability to control muscle movements smoothly and precisely.
Conducted at DNA Labs UAE, a reputable genetic testing facility known for its advanced diagnostic solutions, this test is crucial for early detection and management of the disorder. By analyzing an individual's DNA sample, typically obtained through a blood draw, the test can pinpoint specific genetic alterations in the KIF1C gene that contribute to the manifestation of Spastic Ataxia Type 2.
The cost of the KIF1C Gene Spastic Ataxia Type 2 Autosomal Recessive Genetic Test is set at 4400 AED. Although this price may seem significant, the value of the test lies in its ability to provide essential genetic information. This information not only aids in the accurate diagnosis and understanding of the disorder but also helps in tailoring personalized management plans, potentially improving the quality of life for affected individuals and their families. Early diagnosis through genetic testing can be instrumental in accessing appropriate treatments and support services, making it a valuable investment in the long-term health and well-being of those at risk for or affected by Spastic Ataxia Type 2.
The "MARS2 Gene Spastic Ataxia Type 3 Autosomal Recessive Genetic Test" is a specialized diagnostic tool used to detect mutations in the MARS2 gene, which are linked to Spastic Ataxia Type 3, an autosomal recessive disorder. This condition is characterized by progressive difficulty with coordination and movement, as a result of damage to the part of the brain and spinal cord that controls voluntary movement. The test is vital for early diagnosis and management of the condition, allowing for tailored treatment plans and genetic counseling for affected families. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test costs 4400 AED. This state-of-the-art lab ensures accurate and reliable results, employing advanced genomic technologies to analyze the genetic material for any abnormalities associated with the disorder.
